# Ashwagandha Exercise Recovery Randomized Trial: What the Evidence Says Canonical: https://www.migaku.app/guides/ashwagandha-exercise-recovery-randomized-trial-evidence-review Category: evidence-review Summary: Ashwagandha Exercise Recovery Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first p Last reviewed: 2026-07-26 Reviewed by: Migaku Evidence Review # Ashwagandha Exercise Recovery Randomized Trial: What the Evidence Says ## Quick Answer Ashwagandha Exercise Recovery Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice. ## Key Takeaways - This page is generated only from sources stored in the Migaku evidence knowledge base. - Current evidence mix: 1 systematic review, 1 narrative review. - Claims should be interpreted with the source type, study design, population, and publication date in mind. - This article is educational and does not replace care from a qualified clinician. ## Evidence Map | Source | Evidence type | Level | Date | Identifier | | --- | --- | ---: | --- | --- | | Effects of Withania somnifera (L.) Dunal (Ashwagandha) on cognitive and physical function in adults: a systematic review and meta-analysis | systematic review | 1 | 2026-05-11 | 10.3389/fphar.2026.1799467 | | The Clinical Implications of Ashwagandha ( Withania somnifera L.) with a Special Reference to Side Effects—A Review | narrative review | 3 | 2026-03-09 | 10.3390/nu18050871 | ## What The Sources Report - For example,evaluated nine randomized controlled trials by meta-analysis, and found that the scores of Perceived Stress Questionnaire (PSS), Anxiety Score (HAS) and serum cortisol levels were significantly reduced, indicating that it has a significant anti-pressure effect. [Zhu XiaoLing (2026); evidence level 1] - A study involving 80 healthy subjects aged 18-45 years showed that, compared with the placebo group, the Ashwagandha-supplemented group significantly improved bench press and leg lift strength, arm circumference and chest circumference, thigh circumference, and maximum oxygen uptake (VOmax) (p < 0.05). [Zhu XiaoLing (2026); evidence level 1] - It is important to note that all cellular and biochemical markers of the immune system, which were improved, were still within the normal physiological range of the respective markers, indicating that the treatment did not give rise to uncontrolled immune stimulation. [Winther Kaj (2026); evidence level 3] - In another in vivo rat model, where gout was induced by monosodium urate crystals, edema was reduced to normal levels, indicating a potent anti-inflammatory effect with ashwagandha treatment. [Winther Kaj (2026); evidence level 3] ## How To Read This Evidence Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade. ## Practical Interpretation There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For ashwagandha exercise recovery randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence. ## Limits Of This First Pass This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review. ## References - Zhu XiaoLing (2026). Effects of Withania somnifera (L.) Dunal (Ashwagandha) on cognitive and physical function in adults: a systematic review and meta-analysis. DOI: 10.3389/fphar.2026.1799467. PMCID: PMC13199302. PMID: 42199854. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13199302/ - Winther Kaj (2026). The Clinical Implications of Ashwagandha ( Withania somnifera L.) with a Special Reference to Side Effects—A Review. DOI: 10.3390/nu18050871. PMCID: PMC12986965. PMID: 41830041. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12986965/ ## Safety Note Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.